Fiduciary Financial Services of The Southwest Inc. TX reduced its stake in shares of CVS Health Corp (NYSE:CVS) by 32.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,987 shares of the pharmacy operator’s stock after selling 1,882 shares during the period. Fiduciary Financial Services of The Southwest Inc. TX’s holdings in CVS Health were worth $289,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the stock. Pathstone Family Office LLC grew its holdings in CVS Health by 341.0% during the 2nd quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock worth $2,353,000 after acquiring an additional 982 shares during the period. Wealthcare Advisory Partners LLC grew its holdings in CVS Health by 330.3% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares during the period. Fieldpoint Private Securities LLC grew its holdings in CVS Health by 333.3% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the period. Arcadia Investment Management Corp MI grew its holdings in CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares during the period. Finally, MPS Loria Financial Planners LLC acquired a new stake in CVS Health during the 2nd quarter worth about $119,000. 84.12% of the stock is owned by institutional investors and hedge funds.
CVS has been the subject of a number of recent analyst reports. Deutsche Bank initiated coverage on CVS Health in a report on Monday, December 4th. They set a “buy” rating and a $90.00 price target for the company. Needham & Company LLC increased their price target on CVS Health from $79.00 to $85.00 and gave the stock a “buy” rating in a report on Monday, December 4th. Leerink Swann set a $85.00 price target on CVS Health and gave the stock a “buy” rating in a report on Monday, December 4th. Citigroup set a $76.00 price target on CVS Health and gave the stock a “hold” rating in a report on Monday, December 4th. Finally, Loop Capital set a $73.00 price target on CVS Health and gave the stock a “hold” rating in a report on Monday, December 4th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $87.03.
Shares of CVS Health Corp (NYSE CVS) opened at $69.01 on Tuesday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. The company has a market capitalization of $70,276.63, a PE ratio of 11.70, a PEG ratio of 1.15 and a beta of 1.03. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.00.
CVS Health (NYSE:CVS) last issued its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period last year, the business posted $1.71 EPS. analysts anticipate that CVS Health Corp will post 6.37 earnings per share for the current year.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the transaction, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Helena Foulkes sold 19,965 shares of CVS Health stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the transaction, the executive vice president now owns 65,072 shares of the company’s stock, valued at approximately $4,622,714.88. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: “Fiduciary Financial Services of The Southwest Inc. TX Reduces Stake in CVS Health Corp (CVS)” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://ledgergazette.com/2018/03/13/fiduciary-financial-services-of-the-southwest-inc-tx-reduces-stake-in-cvs-health-corp-cvs.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.